Segments - Adaptogens Market by Applications (Pharmaceuticals, Animal Feed, Dietary Supplements, Cosmetics, and Food & Beverages), Sources (Ginseng, Holy Basil, Ashwagandha, Astragalus, Adaptogenic Mushrooms, Schisandra, and Rhodiola Rosea), Distribution Channels (Online and Offline [Drugstore, Supermarkets/Hypermarkets, and Grocery & Convenience Store]), End-users (Tea & Beverages, Capsule, and Powder), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2030
The global adaptogens market size was valued at around USD 10.5 billion in 2021 and is projected to reach around 23.7 billion by 2030, expanding at a CAGR of 6.9% during the forecast period, 2022–2030. The growth of the market is attributed to growing consumer awareness regarding the undesirable effects of pharmaceutical formulations and conventional drugs in the long term.
Adaptogens are non-toxic plant extracts that help the human body adapt to a variety of stressors and strains. Adaptogens come in a variety of formats, including adaptogen teas and tinctures mixed with water. Adaptogens are also available as a pre-mixed powder that may be ingested with meals. Capsules containing adaptogens are also available. Adaptogens including holy basil, ginseng, schizandra, rhodiola rosea, and ashwagandha are becoming increasingly popular in medicines, nutritional supplements, food and drinks, and cosmetics, among other applications. They improve the body's ability to withstand the negative effects of stress while promoting or restoring normal physiological function. Medicinal mushrooms such as maitake, reishi, and shiitake, and others, have been shown to improve bodily resilience to physical, biological, and chemical stress. Maca has a reputation for enhancing meals and lowering energy levels. Licorice has a reputation for boosting energy and endurance. It also helps to maintain appropriate cortisol levels by boosting the immunological system, stimulating the adrenal glands, and boosting the immune system.
The emergence of the COVID-19 pandemic necessitated the development of effective medicines for the prevention and treatment of acute viral and stress-related diseases. Adaptogens have been demonstrated to be helpful in the prevention and treatment of viral infections at all phases of the inflammatory process, as well as in recovery. The rising significance of adaptogens in COVID-19 therapy aided market expansion during the pandemic.
The report on the global adaptogens market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes | Details |
Report Title | Adaptogens Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year | 2021 |
Historic Data | 2019–2020 |
Forecast Period | 2022–2030 |
Segmentation | Applications (Pharmaceuticals, Animal Feed, Dietary Supplements, Cosmetics, and Food & Beverages), Sources (Ginseng, Holy Basil, Ashwagandha, Astragalus, Adaptogenic Mushrooms, Schisandra, and Rhodiola Rosea), Distribution Channels (Online and Offline [Drugstore, Supermarkets/Hypermarkets, and Grocery & Convenience Store]), and End-users (Tea & Beverages, Capsule, and Powder) |
Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report | MB-Holding GmbH & Co. KG; PLT Health Solutions, Inc.; Xi’an Greena Biotech Co. Ltd.; Amax NutraSource, Inc; NutraCap Labs; Changsha Organic Herb Inc.; REBBL; Nutra Industries Inc.; Organic India; and Xian Yuensun Biological Technology Co. Ltd |
On the basis of applications, the adaptogens market is segregated into pharmaceuticals, animal feed, dietary supplements, cosmetics, and food & beverages. The pharmaceuticals segment is projected to expand at a considerable CAGR during the forecast period, due to rising demand for functional products with natural ingredients. The dietary supplements segment is anticipated to account for a major market share during the forecast period, owing to increasing demand for healthy food and beverages and rising health concerns among individuals.
Based on sources, the market is divided into ginseng, holy basil, ashwagandha, astragalus, adaptogenic mushrooms, schisandra, and rhodiola rosea. The adaptogenic mushrooms segment is expected to hold a significant share of the market in the coming years, due to increasing prevalence of anxiety-associated terminal illness and chronic post-traumatic stress disorder. Adaptogenic mushrooms used in manufacturing psychedelic drugs are used as antidepressant. It helps in easing the symptoms of depression and thus boost the market. The holy basil segment accounts for a significant market share, as it is incorporated in various beverages including coffee, juice, and tea. Holy basil is used in lattes and juice to relieve stress.
On the basis of distribution channels, the adaptogens market is segregated into online and offline. The offline segment is further classified as drugstore, supermarkets/hypermarkets, and grocery & convenience store. The offline segment is anticipated to expand at a substantial CAGR during the forecast period, owing to growing interest among consumers to explore food in offline stores that provide a calming sensation and boost immunity. The online segment is expected to hold a significant share of the market, due to increasing penetration of smartphones and rising trend of digital marketing.
Based on end-users, the market is segmented into tea & beverages, capsule, and powder. The powder segment is projected to register considerable market share in the coming years, as powder form of adaptogens is widely used for formulation of powdered supplements. The tea & beverages segment is expected to expand at substantial CAGR, due to increasing demand for energy drinks with functional benefits such as immunity and mental stimulation.
In terms of regions, the adaptogens market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a key share of the market during the forecast period, owing to rising product demand from pharmaceutical industry in the region. The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period, due to increasing demand for dietary supplements.
Key players competing in the global adaptogens market are MB-Holding GmbH & Co. KG; PLT Health Solutions, Inc.; Xi’an Greena Biotech Co. Ltd.; Amax NutraSource, Inc; NutraCap Labs; Changsha Organic Herb Inc.; REBBL; Nutra Industries Inc.; Organic India; and Xian Yuensun Biological Technology Co. Ltd.
Key players are investing significant resources in product development. Key players are engaging in mergers and acquisitions to increase their market share. Consumer trust is built through e-commerce and consumer awareness activities.
Key players competing in the global adaptogens market are MB-Holding GmbH & Co. KG; PLT Health Solutions, Inc.; Xi’an Greena Biotech Co. Ltd.; Amax NutraSource, Inc; NutraCap Labs; Changsha Organic Herb Inc.; REBBL; Nutra Industries Inc.; Organic India; and Xian Yuensun Biological Technology Co. Ltd.
North America is expected to constitute a key share of the market during the forecast period.
The global adaptogens market is anticipated to expand at a CAGR of 6.9% during the forecast period, 2022–2030.
Use of adaptogens as an ingredient in nutraceutical products ensures protection from flu, which is projected to propel the market during the forecast period.
The global adaptogens market size was valued at around USD 10.5 billion in 2021 during the forecast period, 2022–2030.